Interview with Igor Kouznetsov, General Director, Euroservice
You founded Euroservice, and have managed this business since its inception in 1996. What are the key drivers that have facilitated the growth of this company from a staff of…
Address: 3А, Nagatinskaya Str., Moscow, 117105, Russia
Tel: +7 (495) 231-42-53
Web: http://www.arfp.ru/
The Association of the Russian pharmaceutical manufactures (ARPM) was established in 2002 as a non-commercial partnership bringing together leading Russian pharmaceutical companies. Currently their share in the local market makes more than 60% of medicine produced in Russia, more than 35% of export, and more than 70% of medicine of the domestic manufactures in the DLO/ONLS programme.
The ARPM mission is to develop the Russian pharmaceutical industry for the purpose of providing the population of Russia with modern, high-quality and affordable medicines.
The ARPM actively cooperates with Russian legislative and executive bodies. The ARPM is the member of Russian Chamber of Commerce and Industry.
The ARPM is the winner of the open competition of the professionals of the pharmaceutical market «Platinum Uncia» in the nomination «Public organization» in 2007.
Currently the ARPM unites about 20 pharmaceutical plants which are situated in all Russian regions: Moscow, St. Petersburg, Nizhniy Novgorod, the Urals, Siberia and the Far East.
You founded Euroservice, and have managed this business since its inception in 1996. What are the key drivers that have facilitated the growth of this company from a staff of…
In spring of 2010, Protek became the first Russian wholesaler to enter the public stock market, raising $400Mn in the biggest Russian IPO since 2007. You offered the IPO directly…
PAREXEL prides itself on improving the time schedule of a product launch. What is the significance of time-to-market in the healthcare industry, and how can PAREXEL expedite the process better…
Since our last report on Russia in 2007, there has been much emphasis placed on developing local industry, and reducing the nation’s reliance on imported pharmaceutical products. How do you…
You have been at your current position for less than a year, and joined BIOCODEX after having managed the Russian affiliate of Yves Saint Laurent. You have a long history…
You worked for ten years at Schering-Plough—one of the largest pharmaceutical companies in the world. In February of last year, you joined Merz Pharma, a much smaller player. Some may…
Russia and India have recently held a number of discussions regarding increased cooperation within the pharmaceutical sector. For example, the two nation’s health ministers have discussed decreasing administrative barriers to…
Biofund is an independent spin-off of the broader Russian Venture Capital organization. What is the working relationship and synergy between these agencies, and what are the market conditions that have…
Petrovax has always been an innovative company, making it quite unique in Russia where the domestic industry is predominantly comprised of generics manufacturers. How would you describe the positioning of…
After a long history in Philips, this is your first tenure as a regional CEO. Having been at this position for less than a year, what are your impressions of…
You were a Russian manager from 1996-2004, departed to Germany for some time, and recently made your way back to Russia in 2010. How has Russian healthcare and industry changed,…
You were responsible for merging Pierre Fabre’s activities in Russia in 2008, and heading the new legal entity and 100% subsidiary. What is it like to set up a new…
See our Cookie Privacy Policy Here
